{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:45:17Z","timestamp":1786985117177,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573617"],"award-info":[{"award-number":["81573617"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973487"],"award-info":[{"award-number":["81973487"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374149"],"award-info":[{"award-number":["82374149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bioadv.2023.213683","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T05:51:33Z","timestamp":1698990693000},"page":"213683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Engineered tumor microvesicles modified by SP94 peptide for arsenic trioxide targeting drug delivery in liver cancer therapy"],"prefix":"10.1016","volume":"155","author":[{"given":"Faisal","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beixuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-En","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioadv.2023.213683_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hep.31685","article-title":"Targeting the De novo purine synthesis pathway through adenylosuccinate lyase depletion impairs liver cancer growth by perturbing mitochondrial function","volume":"74","author":"Jiang","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.bioadv.2023.213683_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2023.04.055","article-title":"miR-210 promotes hepatocellular carcinoma progression by modulating macrophage autophagy through PI3K\/AKT\/mTOR signaling","volume":"662","author":"Bi","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioadv.2023.213683_bb0015","doi-asserted-by":"crossref","first-page":"121690","DOI":"10.1016\/j.lfs.2023.121690","article-title":"MALT1 paracaspase is overexpressed in hepatocellular carcinoma and promotes cancer cell survival and growth","volume":"323","author":"Kurden-Pekmezci","year":"2023","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.bioadv.2023.213683_bb0020","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/RLU.0000000000004641","article-title":"Role of 68 Ga-FAPI PET\/CT in assessing hepatobiliary malignancies\u202f: a prospective pilot study","volume":"48","author":"Rajaraman","year":"2023","journal-title":"Clin. Nucl. Med."},{"issue":"6","key":"10.1016\/j.bioadv.2023.213683_bb0025","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bioadv.2023.213683_bb0030","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca-a Cancer Journal for Clinicians"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213683_bb0035","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"Ca-a Cancer Journal for Clinicians"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213683_bb0040","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0168-8278(17)30416-6","article-title":"Tumor derived exsomes mediate tumor infiltrating NK-cell dysfunction in patients with hepatocellular carcinoma via TGF-beta\/SMAD pathway","volume":"66","author":"Yin","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213683_bb0045","first-page":"57","article-title":"Real-world study evaluating the incidence of liver damage conditions in patients with primary liver cancer using immune checkpoint inhibitor-based combination therapy","volume":"30","author":"Hu","year":"2022","journal-title":"Chin. J. Hepatol."},{"issue":"8","key":"10.1016\/j.bioadv.2023.213683_bb0050","first-page":"832","article-title":"The consensus on tertiary prevention of primary liver cancer (2022 version)","volume":"30","author":"Chinese Society of Hepatology, CMA","year":"2022","journal-title":"Chinese Journal of Hepatology"},{"issue":"10","key":"10.1016\/j.bioadv.2023.213683_bb0055","first-page":"1269","article-title":"Chinese expert consensus on management of intrahepatic cholangiocarcinoma (2022 edition)","volume":"21","author":"Chinese Society of Liver Cancer Cholangiocarcinoma Cooperative","year":"2022","journal-title":"Chinese Journal of Dig. Surg."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213683_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Biochimica Et Biophysica Acta-Reviews on Cancer"},{"issue":"9","key":"10.1016\/j.bioadv.2023.213683_bb0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.tips.2013.06.005","article-title":"Cancer drug discovery by repurposing: teaching new tricks to old dogs","volume":"34","author":"Gupta","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"24","key":"10.1016\/j.bioadv.2023.213683_bb0070","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1158\/1078-0432.CCR-10-1277","article-title":"Biologically targeted Cancer therapy and marginal benefits: are we making too much of too little or are we achieving too little by giving too much?","volume":"16","author":"Fojo","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bioadv.2023.213683_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/s10661-019-7495-z","article-title":"Monitoring of arsenic, mercury and organic pesticides in particulate matter, ambient air and settled dust in natural history collections taking the example of the Museum fur Naturkunde, Berlin","volume":"191","author":"Deering","year":"2019","journal-title":"Environmental Monitoring and Assessment"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213683_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3366\/anh.2017.0426","article-title":"Wolfgang Helmgard von Hohberg (1612-1688) and John Woodward (1665-1728): first records of using arsenic and mercury for the preservation of natural history collections","volume":"44","author":"Strekopytov","year":"2017","journal-title":"Archives of Natural History"},{"issue":"23","key":"10.1016\/j.bioadv.2023.213683_bb0085","doi-asserted-by":"crossref","DOI":"10.1007\/s12665-016-6251-8","article-title":"Distribution and enrichment of trace metals and arsenic at the upper layer of sediments from Lerma River in La Piedad, Mexico: case history","volume":"75","author":"Villalobos-Castaneda","year":"2016","journal-title":"Environ. Earth Sci."},{"key":"10.1016\/j.bioadv.2023.213683_bb0090","first-page":"17","article-title":"Cryptotanshinone enhances the effect of arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated-STAT3 in vitro and in vivo","author":"Shen","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"issue":"3","key":"10.1016\/j.bioadv.2023.213683_bb0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/mol.62.3.529","article-title":"Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines","volume":"62","author":"Ling","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioadv.2023.213683_bb0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ajps.2018.12.002","article-title":"Arsenic trioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency","volume":"15","author":"Wang","year":"2020","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"issue":"40","key":"10.1016\/j.bioadv.2023.213683_bb0105","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1039\/C8TB01899E","article-title":"Metal\u2013organic framework nanoparticles for arsenic trioxide drug delivery","volume":"6","author":"Ettlinger","year":"2018","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioadv.2023.213683_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119385","article-title":"Construction of arsenic-metal complexes loaded nanodrugs for solid tumor therapy: a mini review","volume":"583","author":"Fei","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.bioadv.2023.213683_bb0115","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1016\/j.xphs.2020.06.001","article-title":"Prodrug-Like\u2019acetylmannosamine modified liposomes loaded with arsenic trioxide for the treatment of orthotopic glioma in mice","volume":"109","author":"Wang","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2023.213683_bb0120","series-title":"Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles, in Annual Review of Cell and Developmental Biology","first-page":"255","volume":"Vol 30","author":"Colombo","year":"2014"},{"issue":"4","key":"10.1016\/j.bioadv.2023.213683_bb0125","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1182\/blood-2010-09-307595","article-title":"Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters","volume":"117","author":"Gyoergy","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bioadv.2023.213683_bb0130","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCRESAHA.110.226456","article-title":"Microparticles protagonists of a novel communication network for intercellular information exchange","volume":"107","author":"Mause","year":"2010","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213683_bb0135","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/ncomms2282","article-title":"Delivery of chemotherapeutic drugs in tumour cell-derived microparticles","volume":"3","author":"Tang","year":"2012","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioadv.2023.213683_bb0140","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/cr.2016.53","article-title":"Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles","volume":"26","author":"Ma","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.bioadv.2023.213683_bb0145","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.2147\/IJN.S246659","article-title":"HeLa cell-derived paclitaxel-loaded microparticles efficiently inhibit the growth of cervical carcinoma","author":"Peng","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2023.213683_bb0150","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.194.Supp.69.38","article-title":"Oral vaccine by tumor cell-derived microparticles leads to effective anti-tumor immune responses","volume":"194","author":"Huang","year":"2015","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bioadv.2023.213683_bb0155","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1017704","article-title":"Tumor cell-derived microparticles: a new form of cancer vaccine","volume":"4","author":"Zhang","year":"2015","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.bioadv.2023.213683_bb0160","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.leu.2404296","article-title":"Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.bioadv.2023.213683_bb0165","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/cr.2016.53","article-title":"Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles","volume":"26","author":"Ma","year":"2016","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.bioadv.2023.213683_bb0170","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/aps.2017.5","article-title":"New knowledge of the mechanisms of sorafenib resistance in liver cancer","volume":"38","author":"Zhu","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.bioadv.2023.213683_bb0175","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijo.2018.4661","article-title":"From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (review)","volume":"54","author":"Schirrmacher","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.bioadv.2023.213683_bb0180","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nmat3042","article-title":"The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers (vol 10, pg 389, 2011)","volume":"10","author":"Ashley","year":"2011","journal-title":"Nat. Mater."},{"issue":"3","key":"10.1016\/j.bioadv.2023.213683_bb0185","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/nn204102q","article-title":"Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers","volume":"6","author":"Ashley","year":"2012","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.bioadv.2023.213683_bb0190","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1021\/nn201397z","article-title":"Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles","volume":"5","author":"Ashley","year":"2011","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.bioadv.2023.213683_bb0195","doi-asserted-by":"crossref","first-page":"12679","DOI":"10.1021\/acsnano.0c01453","article-title":"A hepatocellular carcinoma targeting nanostrategy with hypoxia-ameliorating and photothermal abilities that, combined with immunotherapy, inhibits metastasis and recurrence","volume":"14","author":"Zhou","year":"2020","journal-title":"Acs Nano"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213683_bb0200","article-title":"A stepwise procedure for isolation of murine bone marrow and generation of dendritic cells","volume":"1","author":"Madaan","year":"2014"},{"issue":"4","key":"10.1016\/j.bioadv.2023.213683_bb0205","first-page":"1683","article-title":"Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment","volume":"12","author":"Xu","year":"2022"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213683_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01358-0","article-title":"Microparticles: Biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research","volume":"20","author":"Hu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.bioadv.2023.213683_bb0215","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1021\/acsnano.9b03288","article-title":"Amplified cancer immunotherapy of a surface-engineered antigenic microparticle vaccine by synergistically modulating tumor microenvironment","volume":"13","author":"Zhao","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2023.213683_bb0220","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Kimiz-Gebologlu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2023.213683_bb0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijbiomac.2018.10.005","article-title":"Doxorubicin-loaded casein nanoparticles for drug delivery: preparation, characterization and in vitro evaluation","volume":"121","author":"Gandhi","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2023.213683_bb0230","first-page":"613","article-title":"Evaluation of protein secondary structure from FTIR spectra improved after partial deuteration","volume":"50","author":"De Meutter","year":"2021"},{"issue":"2","key":"10.1016\/j.bioadv.2023.213683_bb0235","first-page":"3123","article-title":"Immunogenic hybrid nanovesicles of liposomes and tumor-derived nanovesicles for cancer immunochemotherapy","volume":"15","author":"Hu","year":"2021"},{"key":"10.1016\/j.bioadv.2023.213683_bb0240","doi-asserted-by":"crossref","unstructured":"Zhang, M., et al., A review of biomimetic nanoparticle drug delivery systems based on cell membranes. 2020: p. 5495\u20135503.","DOI":"10.2147\/DDDT.S282368"},{"issue":"6","key":"10.1016\/j.bioadv.2023.213683_bb0245","first-page":"2480","article-title":"An extracellular pH-driven targeted multifunctional manganese arsenite delivery system for tumor imaging and therapy","volume":"7","author":"Zhang","year":"2019"},{"key":"10.1016\/j.bioadv.2023.213683_bb0250","article-title":"Tumor micro-environment sensitive release of doxorubicin through chitosan based polymeric nanoparticles: an in-vitro study","volume":"313","author":"Akram","year":"2023"},{"key":"10.1016\/j.bioadv.2023.213683_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.140437","article-title":"NIR-II fluorescence imaging-guided hepatocellular carcinoma treatment via IR-1061-acridine and lenvatinib co-loaded thermal-sensitive micelles and anti-PD-1 combinational therapy","volume":"454","author":"Du","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"4","key":"10.1016\/j.bioadv.2023.213683_bb0260","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1021\/acsami.7b14496","article-title":"Enhancing the efficacy and safety of doxorubicin against hepatocellular carcinoma through a modular assembly approach: the combination of polymeric prodrug design, nanoparticle encapsulation, and cancer cell-specific drug targeting","volume":"10","author":"Xu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2023.213683_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2022.100220","article-title":"Enhanced fluorescence\/magnetic resonance dual imaging and gene therapy of liver cancer using cationized amylose nanoprobe","volume":"13","author":"Zhang","year":"2022","journal-title":"Materials Today Bio"},{"key":"10.1016\/j.bioadv.2023.213683_bb0270","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.2147\/IJN.S366180","article-title":"GA&HA-modified liposomes for co-delivery of aprepitant and curcumin to inhibit drug-resistance and metastasis of hepatocellular carcinoma","author":"Li","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2023.213683_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01655-7","article-title":"SP94 peptide-functionalized PEG-PLGA nanoparticle loading with cryptotanshinone for targeting therapy of hepatocellular carcinoma","volume":"21","author":"Nie","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.bioadv.2023.213683_bb0280","first-page":"35","article-title":"Tumor-derived exosomes and their role in tumor-induced immune suppression","volume":"4","author":"Whiteside","year":"2016"},{"key":"10.1016\/j.bioadv.2023.213683_bb0285","first-page":"2481","article-title":"Tumor-derived microvesicles enhance cross-processing ability of clinical grade dendritic cells","volume":"9","author":"Dionisi","year":"2018"},{"key":"10.1016\/j.bioadv.2023.213683_bb0290","first-page":"1","article-title":"Tumor-derived exosomes induce CD8+ T cell suppressors","volume":"5","author":"Maybruck","year":"2017"},{"key":"10.1016\/j.bioadv.2023.213683_bb0295","first-page":"221","article-title":"Engineered tumor-derived extracellular vesicles: potentials in cancer immunotherapy","volume":"11","author":"Taghikhani","year":"2020"},{"key":"10.1016\/j.bioadv.2023.213683_bb0300","doi-asserted-by":"crossref","unstructured":"Shao, J., J. Zaro, and Y.J.I.J.O.N. Shen, Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate. 2020: p. 9355\u20139371.","DOI":"10.2147\/IJN.S281890"},{"issue":"8","key":"10.1016\/j.bioadv.2023.213683_bb0305","first-page":"3474","article-title":"Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs","volume":"10","author":"Qiao","year":"2020"},{"key":"10.1016\/j.bioadv.2023.213683_bb0310","first-page":"39","article-title":"Ki-67 protein as a tumour proliferation marker","volume":"491","author":"Menon","year":"2019"},{"issue":"26","key":"10.1016\/j.bioadv.2023.213683_bb0315","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2217\/nnm-2022-0250","article-title":"Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy","volume":"17","author":"Sun","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2023.213683_bb0320","first-page":"1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950823004065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950823004065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:34:06Z","timestamp":1762648446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950823004065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":64,"alternative-id":["S2772950823004065"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2023.213683","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered tumor microvesicles modified by SP94 peptide for arsenic trioxide targeting drug delivery in liver cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2023.213683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"213683"}}